ACN Investors - Our Quick Report For You.

By Naomi Wentworth • Thursday, January 12 10:36 • Permanent Link

Accenture logged a 1.9% change during today's morning session, and is now trading at a price of $286.51 per share. The S&P 500 index moved 0.2%. ACN's trading volume is 470,949 compared to the stock's average volume of 2,172,856.

The one analyst following Accenture has given it a rating of buy and a target price of $307.18 per share. Now, the company is currently trading -6.73% away from its target price.

If you are considering an investment in ACN, you'll want to know the following:

Accenture's current price is 279.8% above its Graham number of $75.43, which implies that at its current valuation it does not offer a margin of safety
Based on its trailing earnings per share of 8.45, Accenture has a trailing 12 month Price to Earnings (P/E) ratio of 33.9 while the S&P 500 average is 15.97
ACN has a forward P/E ratio of 30.5 based on its forward 12 month price to earnings (EPS) of $9.38 per share
The company has a price to earnings growth (PEG) ratio of 2.03 — a number near or below 1 signifying that Accenture is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 9.9 compared to its sector average of 5.57
Accenture plc, a professional services company, provides strategy and consulting, interactive, and technology and operation services worldwide.
Based in Dublin, the company has 721,000 full time employees and a market cap of $181,223,325,696. Accenture currently returns an annual dividend yield of 1.2%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.